Filter posts

Always Learning: Networking Opportunities at the BIO International Convention

After we wrapped up our last BIO International Convention – we took the time to …

My First Blog Entry: An Enlivened Biotech Industry and BIO International Convention

While Washington, DC struggles with yet another round of cold temperatures, inside the halls of …

Find Your Next Asia Partnership in Tokyo at BIO Asia

On April 8-9, 2014, the BIO Asia International Conference will enter its eleventh year. This year, biopharma …

The Economist – Biotechnology: Fever Rising

After speaking with several attendees and speakers at last week’s BIO CEO & Investor Conference, the …

Business Roundtable: The Reimbursement Landscape under ACA

As the Affordable Care Act is implemented, reimbursement for life-saving and life-enhancing drugs is one …

#BIOCEO14: An Optimistic Outlook for 2014

The 16th Annual BIO CEO & Investor Conference​ concluded with a lively Closing Plenary Session examining …

Fireside Chat with Allergan CEO, David Pyott

Day two of the 16th Annual BIO CEO & Investor Conference​ kicked off with a Fireside Chat featuring one …

Open Communication Helps Reduce Rare Disease Drug Development Risk

One of the most important keys to successful relationships – be it in life or …

Sanofi’s Chris Viehbacher: Trust, Respect Key in Pharma-Biotech Partnerships

How can large pharmaceutical and small biotech companies form mutually beneficial partnerships that harness the …

What's New in RNAi Therapeutics?

At the 16th Annual BIO CEO & Investor Conference​, Monday morning’s therapeutic workshop, “Delivering the (RNAi) …